EUVIMEDEUVIMED entdecken
Crossref

Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case

Journal of Oncology Research and Therapy · 12.09.2025 · 10 (3)

DOI: 10.29011/2574-710x.10304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Research and Therapy, online erschienen am 12.09.2025. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2025). Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case. Journal of Oncology Research and Therapy, 10(3). https://doi.org/10.29011/2574-710x.10304

Vancouver

Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case. Journal of Oncology Research and Therapy. 2025;10(3). doi:10.29011/2574-710x.10304

BibTeX
@article{euvimed2025,
  title = {Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case},
  journal = {Journal of Oncology Research and Therapy},
  year = {2025},
  volume = {10},
  number = {3},
  doi = {10.29011/2574-710x.10304}
}
Kostenlos starten →